Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01503554 · ClinicalTrials.gov registry record · NA
Combined Social Worker and Pharmacist Transitional Care Program
A NA study of Patient Discharge and Patient Admission, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT01503554: Completed NA study of Patient Discharge and Patient Admission, sponsored by Rush University Medical Center.
NCT01503554 is a NA study of Patient Discharge and Patient Admission that has completed, run by Rush University Medical Center. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01503554, a NA study of Patient Discharge and Patient Admission, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
In an effort to improve care coordination and reduce hospital readmissions, Rush University Medical Center developed the Combined Social Worker and Pharmacist Program, which targets both the psychosocial and clinical risk factors that can lead to rehospitalization. This study will evaluate the impact of this program on 30-day same hospital readmission rates and total cost of care.
Conditions Studied
Interventions
- BEHAVIORAL Combined Social Worker and Pharmacist Program
- BEHAVIORAL No Intervention: Usual Care
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-04 |
| Est. Completion | 2011-12 |
| Phase | NA |
What the finished NCT01503554 record still lists
NCT01503554 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Patient Discharge appearing as the primary indexed condition, and to 2 interventions - of which Combined Social Worker and Pharmacist Program is the first listed.
NCT01503554 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT01503554 about?
NCT01503554 is a clinical study titled "Combined Social Worker and Pharmacist Transitional Care Program". In an effort to improve care coordination and reduce hospital readmissions, Rush University Medical Center developed the Combined Social Worker and Pharmacist Program, which targets both the psychosocial and clinical risk factors that can lead to rehospitalization. This study will evaluate the impac...
What is the current status of trial NCT01503554?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2011-04. Estimated completion is 2011-12.
What conditions does trial NCT01503554 study?
This clinical trial studies the following conditions: Patient Discharge, Patient Admission.
What interventions are being tested in trial NCT01503554?
The interventions under investigation include: Combined Social Worker and Pharmacist Program (BEHAVIORAL), No Intervention: Usual Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT01503554?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01503554 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Patient Discharge
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01503554's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia